4.8 Article

Longitudinal dynamics of clonal hematopoiesis identifies gene-specific fitness effects

期刊

NATURE MEDICINE
卷 28, 期 7, 页码 1439-+

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41591-022-01883-3

关键词

-

资金

  1. UK's Biotechnology and Biological Sciences Research Council (BBSRC) [SR176]
  2. Royal Society-Wolfson Research Merit Award
  3. Chief Scientist Office of the Scottish Government's Health Directorates [CZB/4/505, ETM/55]
  4. BBSRC [BB/W008793/1]
  5. Economic and Social Research Council [BB/W008793/1]
  6. Age UK (Disconnected Mind project)
  7. Medical Research Council [MR/M01311/1, MR/K026992/1, MR/N013166/1, MC_UU_00009/2]
  8. University of Edinburgh
  9. John Goldman Fellowship
  10. Leukaemia U.K. [2019/JGF/003]
  11. CRUK Glasgow Centre [C7932/A25142]
  12. CRUK Scotland Centre [CTRQQR-2021\100006]
  13. Chancellor's Fellowships held at the University of Edinburgh
  14. University of Edinburgh [MC_UU_00009/2]
  15. Wellcome Trust [221890/Z/20/Z]
  16. Royal Society [221890/Z/20/Z]
  17. Howat Foundation
  18. Wellcome Trust [221890/Z/20/Z] Funding Source: researchfish
  19. Wellcome Trust [221890/Z/20/Z] Funding Source: Wellcome Trust

向作者/读者索取更多资源

An analysis of blood samples reveals insights on the dynamics of clonal hematopoiesis and proposes a model for individualized clone monitoring. This model could help in understanding the relationship between clonal hematopoiesis and increased risk for malignancy, heart disease, and ischemic stroke.
An analysis of blood samples from longitudinal cohorts reveals insights on the dynamics of clonal hematopoiesis of indeterminate potential and proposes a model that could be used for individualized clone monitoring over time. Clonal hematopoiesis of indeterminate potential (CHIP) increases rapidly in prevalence beyond age 60 and has been associated with increased risk for malignancy, heart disease and ischemic stroke. CHIP is driven by somatic mutations in hematopoietic stem and progenitor cells (HSPCs). Because mutations in HSPCs often drive leukemia, we hypothesized that HSPC fitness substantially contributes to transformation from CHIP to leukemia. HSPC fitness is defined as the proliferative advantage over cells carrying no or only neutral mutations. If mutations in different genes lead to distinct fitness advantages, this could enable patient stratification. We quantified the fitness effects of mutations over 12 years in older age using longitudinal sequencing and developed a filtering method that considers individual mutational context alongside mutation co-occurrence to quantify the growth potential of variants within individuals. We found that gene-specific fitness differences can outweigh inter-individual variation and, therefore, could form the basis for personalized clinical management.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据